Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

This study has been completed.
Information provided by (Responsible Party):
Dr. Richard Schlenk, University of Ulm Identifier:
First received: September 6, 2005
Last updated: July 22, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
No publications provided by University of Ulm

Publications automatically indexed to this study by Identifier (NCT Number):